Related Experiment Video
Updated: Aug 15, 2026

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
Protection by Osbeckia aspera against carbon tetrachloride-mediated alterations in microsomal drug metabolizing
1Department of Biochemistry, Faculty of Medicine, University of Ruhuna, Sri Lanka.
Abstract:
Previous investigations have confirmed the protective effect of Osbeckia aspera leaf extract on carbon tetrachloride-mediated liver injury in rat models. It is well known that the earliest alterations in liver cell structure and function following carbon tetrachloride poisoning involve the endoplasmic reticulum and its drug metabolizing enzymes. Therefore, we investigated whether an aqueous leaf extract of O. aspera could offer protection against carbon tetrachloride-induced changes in the microsomal drug metabolizing enzymes aniline hydroxylase and p-aminopyrine N-demethylase. This enzyme activity was compared with phenobarbital-induced righting reflex and lipid peroxidation. Treatment of rats with the aqueous leaf extract of O. aspera (before or after the administration of carbon tetrachloride) resulted in a marked decrease in carbon tetrachloride-mediated alterations in aniline hydroxylase and p-aminopyrine N-demethylase activity, phenobarbital-induced loss of righting reflex and malondialdehyde formation due to lipid peroxidation. The Km value of these enzymes in control and Osbeckia-treated rats were the same. These results show that the plant extract can markedly decrease the carbon tetrachloride-mediated reduction in aniline hydroxylase and p-aminopyrine N-demethylase activity and inhibit peroxidative damage to the cell membrane. Phenobarbital-induced sleeping time in rats and kinetic enzyme studies suggested that the effects of the plant extract was neither due to an induction of the drug-metabolizing enzymes under investigation, nor due to an alteration in the Km values of these enzymes.
Insights
Osbeckia aspera leaf extract protects against liver damage by reducing alterations in drug-metabolizing enzymes and inhibiting lipid peroxidation. The extract
Area of Science:
- Pharmacology
- Hepatoprotective Agents
- Natural Product Chemistry
Background:
- Carbon tetrachloride (CCl4) induces liver injury, primarily affecting endoplasmic reticulum and drug-metabolizing enzymes.
- Aniline hydroxylase and p-aminopyrine N-demethylase are key microsomal enzymes sensitive to CCl4 toxicity.
- Lipid peroxidation is a significant marker of CCl4-induced cellular damage.
Purpose of the Study:
- To investigate the protective effects of Osbeckia aspera leaf extract against CCl4-induced liver injury.
- To determine the impact of the extract on specific drug-metabolizing enzymes (aniline hydroxylase, p-aminopyrine N-demethylase).
- To evaluate the extract's influence on phenobarbital-induced responses and lipid peroxidation.
Main Methods:
- Administration of aqueous Osbeckia aspera leaf extract to rats before or after CCl4 exposure.
- Measurement of aniline hydroxylase and p-aminopyrine N-demethylase activities.
- Assessment of phenobarbital-induced righting reflex duration and malondialdehyde (MDA) levels for lipid peroxidation.
Main Results:
- Osbeckia aspera extract significantly reduced CCl4-induced alterations in enzyme activities.
- The extract mitigated CCl4-mediated lipid peroxidation, indicated by lower MDA formation.
- Phenobarbital-induced sleeping time was normalized, and enzyme kinetics (Km values) remained unchanged, suggesting no induction or alteration of enzyme affinity.
Conclusions:
- Osbeckia aspera leaf extract demonstrates significant hepatoprotective effects against CCl4-induced liver damage.
- The extract protects liver cells by preserving drug-metabolizing enzyme function and inhibiting oxidative stress.
- The protective mechanism does not involve enzyme induction or altered substrate affinity, highlighting a unique mode of action.
More Related Videos
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
08:03Unveiling Xenobiotic Transport and Effects in Isolated Mitochondria: Insights from Respirometric and Enzymatic Assays
Published on: March 7, 2025
Related Concept Videos
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Acetals and Thioacetals as Protecting Groups for Aldehydes and Ketones
In the presence of multiple functional groups, when selective reduction of one group over the other is desired, groups like aldehydes and ketones that form acetals...
Drug Biotransformation: Overview
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase